Methylphenidate side effect profile is influenced by genetic variation in the attention-deficit/hyperactivity disorder-associated CES1 gene

Katherine A Johnson, Edwina Barry, David Lambert, Michael F Fitzgerald, Fiona McNicholas, Aiveen Kirley, Michael Gill, Mark Andrew Bellgrove, Ziarih Hawi

Research output: Contribution to journalArticleResearchpeer-review

32 Citations (Scopus)

Abstract

A naturalistic, prospective study of the influence of genetic variation on dose prescribed, clinical response, and side effects related to stimulant medication in 77 children with attention-deficit/hyperactivity disorder (ADHD) was undertaken. The influence of genetic variation of the CES1 gene coding for carboxylesterase 1A1 (CES1A1), the major enzyme responsible for the first-pass, stereoselective metabolism of methylphenidate, was investigated.
Original languageEnglish
Pages (from-to)655 - 664
Number of pages10
JournalJournal of Child and Adolescent Psychopharmacology
Volume23
Issue number10
DOIs
Publication statusPublished - 2013

Cite this